Hikma to buy Egypt's Alkan Pharma for $60.5 mln

LONDON Thu Aug 9, 2007 7:14am BST

Related Topics



LONDON Aug 9 (Reuters) - Jordanian drugmaker Hikma Pharmaceuticals Plc (HIK.L) said on Thursday it had agreed to buy Alkan Pharma for $60.5 million cash to enter the Egyptian pharmaceuticals market.

Hikma said the deal was scheduled to complete in the second half of this year and would be funded by debt.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.